
Livzon Pharmaceutical Group Inc
SZSE:000513

Livzon Pharmaceutical Group Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
34.13
41.48
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Livzon Pharmaceutical Group Inc hold over its rivals?
What risks and challenges
does Livzon Pharmaceutical Group Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Livzon Pharmaceutical Group Inc.
Provide an overview of the primary business activities
of Livzon Pharmaceutical Group Inc.
What unique competitive advantages
does Livzon Pharmaceutical Group Inc hold over its rivals?
What risks and challenges
does Livzon Pharmaceutical Group Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Livzon Pharmaceutical Group Inc.
Provide P/S
for Livzon Pharmaceutical Group Inc.
Provide P/E
for Livzon Pharmaceutical Group Inc.
Provide P/OCF
for Livzon Pharmaceutical Group Inc.
Provide P/FCFE
for Livzon Pharmaceutical Group Inc.
Provide P/B
for Livzon Pharmaceutical Group Inc.
Provide EV/S
for Livzon Pharmaceutical Group Inc.
Provide EV/GP
for Livzon Pharmaceutical Group Inc.
Provide EV/EBITDA
for Livzon Pharmaceutical Group Inc.
Provide EV/EBIT
for Livzon Pharmaceutical Group Inc.
Provide EV/OCF
for Livzon Pharmaceutical Group Inc.
Provide EV/FCFF
for Livzon Pharmaceutical Group Inc.
Provide EV/IC
for Livzon Pharmaceutical Group Inc.
Show me price targets
for Livzon Pharmaceutical Group Inc made by professional analysts.
What are the Revenue projections
for Livzon Pharmaceutical Group Inc?
How accurate were the past Revenue estimates
for Livzon Pharmaceutical Group Inc?
What are the Net Income projections
for Livzon Pharmaceutical Group Inc?
How accurate were the past Net Income estimates
for Livzon Pharmaceutical Group Inc?
What are the EPS projections
for Livzon Pharmaceutical Group Inc?
How accurate were the past EPS estimates
for Livzon Pharmaceutical Group Inc?
What are the EBIT projections
for Livzon Pharmaceutical Group Inc?
How accurate were the past EBIT estimates
for Livzon Pharmaceutical Group Inc?
Compare the revenue forecasts
for Livzon Pharmaceutical Group Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Livzon Pharmaceutical Group Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Livzon Pharmaceutical Group Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Livzon Pharmaceutical Group Inc compared to its peers.
Compare the P/E ratios
of Livzon Pharmaceutical Group Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Livzon Pharmaceutical Group Inc with its peers.
Analyze the financial leverage
of Livzon Pharmaceutical Group Inc compared to its main competitors.
Show all profitability ratios
for Livzon Pharmaceutical Group Inc.
Provide ROE
for Livzon Pharmaceutical Group Inc.
Provide ROA
for Livzon Pharmaceutical Group Inc.
Provide ROIC
for Livzon Pharmaceutical Group Inc.
Provide ROCE
for Livzon Pharmaceutical Group Inc.
Provide Gross Margin
for Livzon Pharmaceutical Group Inc.
Provide Operating Margin
for Livzon Pharmaceutical Group Inc.
Provide Net Margin
for Livzon Pharmaceutical Group Inc.
Provide FCF Margin
for Livzon Pharmaceutical Group Inc.
Show all solvency ratios
for Livzon Pharmaceutical Group Inc.
Provide D/E Ratio
for Livzon Pharmaceutical Group Inc.
Provide D/A Ratio
for Livzon Pharmaceutical Group Inc.
Provide Interest Coverage Ratio
for Livzon Pharmaceutical Group Inc.
Provide Altman Z-Score Ratio
for Livzon Pharmaceutical Group Inc.
Provide Quick Ratio
for Livzon Pharmaceutical Group Inc.
Provide Current Ratio
for Livzon Pharmaceutical Group Inc.
Provide Cash Ratio
for Livzon Pharmaceutical Group Inc.
What is the historical Revenue growth
over the last 5 years for Livzon Pharmaceutical Group Inc?
What is the historical Net Income growth
over the last 5 years for Livzon Pharmaceutical Group Inc?
What is the current Free Cash Flow
of Livzon Pharmaceutical Group Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Livzon Pharmaceutical Group Inc.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CN |
![]() |
Livzon Pharmaceutical Group Inc
SZSE:000513
|
33.4B CNY | 2.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.3B USD | 17.3 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394.1B USD | 4.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 7.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
234.8B CHF | 4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.3B CHF | 4.4 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
176.3B GBP | 4.2 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.7B USD | 3.5 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 72.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
141.7B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
CN |
![]() |
Livzon Pharmaceutical Group Inc
SZSE:000513
|
Average P/S:
63.7
2.8
|
2%
|
1.4 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17.3
|
22%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.4
|
3%
|
1.5 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
7.3
|
17%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
4
|
5%
|
0.8 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.2
|
7%
|
0.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.5
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
72.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
0%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.